Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. (Q33350682)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

author name string

László Herszényi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Fabio Farinati

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Romilda Cardin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Gábor István

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

László D Molnár

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Massimo De Paoli

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Mario Plebani

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Zsolt Tulassay

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

10 July 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

194

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-194

0 references

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic factors of young patients with colon cancer after surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Carcinoembryonic antigen and recurrent colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

The clinical relevance of tumor marker CEA, CA 19-9 in regional chemotherapy of hepatic metastases of colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Cathepsin B and cystatins: evidence for a role in cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Tumor invasion and metastasis: an imbalance of positive and negative regulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients with colorectal carcinoma: possible prognostic value of tissular carbohydrate antigen 19.9 determination

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the colon: the influence of the no-touch isolation technic on survival rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cysteine and serine proteases in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cysteine and serine proteases in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-194

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33350682&oldid=1959128743"